No you are wrong again.
The USFDA has not changed it rules. USFDA has always required Clinical Trials under CFR21 to support an FDA Registration of Infant Formula, called a PER Study. Due to the cost of these trials $3M-$5M, only multinational companies ever registered with USFDA, but anyone could.
The recent "enforcement discretion" from USFDA was a process where the USFDA granted concession ( at their discretion ) on the requirement of Clinical Trials to gain approval. BUBS jumped in ( and paid Joe Hockey $2M to make some phone calls ) and got approved to address the formula shortage.
However - now BUBS must complete the PER Clinical Trials to remain in the US long term. Bye Bye $5M.
The USFDA is simply a rigorous and expensive process, but it's always been open to everyone. It's not biased like China's SAMR.
No you are wrong again.The USFDA has not changed it rules. USFDA...
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $129.3M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 15.0¢ | 14.5¢ | $218.8K | 1.502M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1163865 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 1553235 | 27 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
14.8¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 14.8¢ | 14.8¢ | 14.5¢ | 375198 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| BUB (ASX) Chart |